Q1 Earnings Forecast for ATNM Issued By B. Riley
Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Free Report) – Equities researchers at B. Riley issued their Q1 2025 earnings per share (EPS) estimates for shares of Actinium Pharmaceuticals in a report released on Tuesday, April 1st. B. Riley analyst Y. Zhi expects that the company will post earnings per share of ($0.26) for the quarter. The […]
